SSA
KRTX

Schonfeld Strategic Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,762
Closed -$5.94M – 2514
2023
Q4 		$5.94M Sell
18,762
-1,151
-6% -$224K 0.04% 485
2023
Q3 		$3.37M Buy
19,913
+2,717
+16% +$511K 0.03% 661
2023
Q2 		$3.73M Sell
17,196
-14,044
-45% -$3.01M 0.03% 568
2023
Q1 		$5.67M Buy
31,240
+18,040
+137% +$3.45M 0.05% 410
2022
Q4 		$2.59M Buy
13,200
+1,886
+17% +$404K 0.02% 718
2022
Q3 		$2.54M Sell
11,314
-2,986
-21% -$604K 0.02% 773
2022
Q2 		$1.81M Buy
14,300
+3,900
+38% +$448K 0.02% 781
2022
Q1 		$1.32M Buy
+10,400
New +$1.17M 0.01% 872

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Schonfeld Strategic Advisors's KRTX Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 18,762 shares — an estimated $5.94M sold.

Schonfeld Strategic Advisors first reported a position in KRTX in Q1 2022 and held it in 8 quarters. The position peaked at $5.94M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 18,762 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $5.94M.
  • Schonfeld Strategic Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $5.94M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.